CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-20 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +159,000 | 159,000 | ||
| 2016-09-29 | Sherman Matthew L Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +150,200 | 150,200 | ||
| 2016-02-03 | ROCKLAGE SCOTT M Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +150,200 | 150,200 | ||
| 2016-02-03 | Graves Kurt Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2016-02-03 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +318,000 | 318,000 | ||
| 2015-12-08 | Graves Kurt Director | Grant or award · Stock Option (Right to Buy) | +18,818 | 18,818 | ||
| 2015-12-08 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +73,481 | 73,481 | ||
| 2015-06-24 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +2,217 | 2,217 | ||
| 2015-06-24 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +44,341 | 44,341 | ||
| 2015-06-24 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +20,508 | 20,508 | ||
| 2015-06-24 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +235,224 | 235,224 | ||
| 2015-06-24 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +1,108 | 1,108 | ||
| 2015-06-24 | ROCKLAGE SCOTT M Director | Grant or award · Stock Option (Right to Buy) | +1,108 | 1,108 | ||
| 2015-06-24 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +1,108 | 1,108 | ||
| 2015-06-15 | Maki David Director | Grant or award · Warrants to Purchase Common Stock | +398,754 | 398,754 |
Page 7 of 8 · 154 trades